CreditReports.dk
HomeScreen companies

Pharma Insight ApS Financials, key figures and credit report

CVR number: 40637117 Established 2019 Industry: 74 Other professional, scientific and technical activities
Company contact details
Mathildevej 10, 2000 Frederiksberg
Gross profit 342.2 kDKK FY 2025 +147.2% vs 2024
EBIT 342.2 kDKK FY 2025 +147.2% vs 2024
Net debt - 340.1 kDKK FY 2025 -110.9% vs 2024
Quick ratio 3.4 FY 2025 -0 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit725.06-27.01-17.12138.46342.21
Employee benefit expenses- 661.50-1.25
EBIT63.56-28.26-17.12138.46342.21
Other financial income0.952.410.180.480.03
Other financial expenses-1.94-0.76-1.92-1.01-1.79
Pre-tax profit62.57-26.61-18.86137.92340.44
Income taxes-14.63-20.17-75.28
Net earnings47.94-26.61-18.86117.75265.16

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors16.0082.91
Current amounts owed by group member comp.77.9282.82
Current other receivables3.673.243.091.56
Short term receivables total81.5986.063.0916.0084.47
Cash and bank deposits327.4469.7544.22189.85399.67
Cash and cash equivalents327.4469.7544.22189.85399.67
Balance sheet total (assets)409.03155.8147.31205.85484.13

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital40.0040.0040.0040.0040.00
Shares repurchased100.00100.0070.00200.00
Retained earnings84.8832.826.20-82.66- 164.91
Profit of the financial year47.94-26.61-18.86117.75265.16
Shareholders equity total272.82146.2027.35145.09340.25
Non-current liabilities total
Current trade creditors10.007.507.508.509.00
Current owed to participating22.889.875.36
Current owed to group member10.6318.7554.23
Short-term deferred tax liabilities14.6320.1775.28
Other non-interest bearing current liabilities88.702.111.843.47
Current liabilities total136.219.6119.9760.76143.88
Balance sheet total (liabilities)409.03155.8147.31205.85484.13
Page generated